Holen Sie sich die Stockscreener-App
1.37
2.14%
-0.03
Handel nachbörslich:
1.37
Medicinova Inc Aktie (MNOV) Neueste Nachrichten
MNOV Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesEarnings Cycle Outlook - Newser
MNOV Stock Price, Quote & Chart | MEDICINOVA INC (NASDAQ:MNOV) - ChartMill
MNOV Q1 2026 Earnings: Drug Development Progress Drives Narrower-than-Expected LossHigh Attention Stocks - Newser
MediciNova Inc stock (US58468P2038): biotech eyes IPF and neurology pipeline as investors watch next - AD HOC NEWS
MSN Money - MSN
MediciNova, Inc.Common Stock (NQ: MNOV - FinancialContent
MediciNova stock (US58468P2038): Earnings update after April study news - AD HOC NEWS
We Think MediciNova (NASDAQ:MNOV) Can Afford To Drive Business Growth - Yahoo Finance
MediciNova Inc reports results for the quarter ended March 31Earnings Summary - TradingView
MediciNova: Q1 Earnings Snapshot - KTVB
MediciNova, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MediciNova (MNOV) Q1 2026 results show lower loss and $27.3M cash - Stock Titan
Medici Nova Biotechnology (MNOV.US) will release its earnings report after the market closes on May 15. - Moomoo
MediciNova Inc stock (US58468P2038): Biopharma innovator targeting unmet needs - AD HOC NEWS
TradingKey - TradingKey
What Medicinova (MNOV) is doing to earn customer loyalty (Tick Down) 2026-05-08Viral Momentum Stocks - newser.com
MediciNova Is Maintained at Buy by D. Boral Capital - Moomoo
D. Boral Capital Reiterates Buy Rating for MediciNova (NASDAQ:MNOV) - MarketBeat
Why are smart money investors paying attention to Medicinova (MNOV)? (Institutional Demand) 2026-05-03Popular Picks - newser.com
MediciNova, Inc. (NASDAQ:MNOV) Sees Large Decrease in Short Interest - MarketBeat
MediciNova Heads to ROTH, Puts Late-Stage Pipeline in Investor Spotlight - BriefGlance
MediciNova (NASDAQ: MNOV) proxy targets 247M authorized shares, board elections - Stock Titan
New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation - Weekly Voice
New Peer‑Reviewed Study Reveals Actionable - GlobeNewswire
D. Boral Capital Maintains MediciNova (MNOV) Buy Recommendation - MSN
Researchers found a brain metastasis weakness — MediciNova plans clinical work - Stock Titan
MediciNova (NASDAQ: MNOV) to vote on 147M share increase, director slate - Stock Titan
Valuation Metrics Overview | Medicinova posts narrower than expected loss, 48.4% EPS beatShared Momentum Picks - Newser
MediciNova (MNOV) asks shareholders to approve 147M share increase ahead of June meeting - Stock Titan
MediciNova, Inc. (NASDAQ:MNOV) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
MediciNova (NASDAQ:MNOV) Share Price Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
What is the bear case for Medicinova (MNOV) Stock | Price at $1.48, Down 1.01%Support Bounce - Xã Châu Thành
Gainers Report: What is the next catalyst for MediciNova IncMarket Sentiment Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Nasdaq Moves: Whats the MACD signal for MediciNova Inc2026 Spike Watch & Breakout Confirmation Trade Signals - baoquankhu1.vn
Fed Meeting: What is the next catalyst for MediciNova IncRecession Risk & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
MediciNova (NASDAQ:MNOV) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Investor Mood: What analysts say about MediciNova Inc stockSell Signal & Daily Profit Focused Stock Screening - baoquankhu1.vn
Can MediciNova Inc expand its profit marginsQuarterly Growth Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
BYSI PE Ratio & Valuation, Is BYSI Overvalued - Intellectia AI
Sentiment Watch: How sensitive is MediciNova Inc to inflationWeekly Investment Report & Expert Curated Trade Setups - baoquankhu1.vn
Will Medicinova (MNOV) Stock Hit Record Highs | Price at $1.44, Up 1.41%Hull Moving Average - Newser
Buy Signal: What is the next catalyst for MediciNova IncEarnings Risk Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Winners Losers: Can MediciNova Inc beat the S P 500Forecast Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Medicinova Inc (NASDAQ:MNOV) Reiterates Buy Rating - FXDailyReport.Com
Maxim Group Maintains MediciNova(MNOV.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Maxim Group Reiterates "Buy" Rating for MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MediciNova Inc stock draws attention amid biotech pipeline momentum and analyst upside calls - AD HOC NEWS
MediciNova (NASDAQ:MNOV) Upgraded at Zacks Research - Defense World
MediciNova (NASDAQ:MNOV) Raised to "Hold" at Zacks Research - MarketBeat
What is HC Wainwright’s Estimate for MediciNova Q1 Earnings? - Defense World
Q1 Earnings Estimate for MediciNova Issued By HC Wainwright - MarketBeat
HC Wainwright & Co. initiates coverage of MediciNova (MNOV) with buy recommendation - MSN
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):